What does the antibody cocktail approved by India contain and how does it work?
Team Udayavani, May 8, 2021, 1:00 PM IST
Pharma giant Roche India has received the Emergency Use Authorisation (EUA) for a COVID-19 antibody-drug cocktail in the country for the treatment of Covid-19 patients.
What is it?
Roche’s antibody cocktail contains two antibodies, casirivimab and imdevimab and is used for the treatment of mild-to-moderate Covid-19 in high-risk patients. It is developed by Roche and Regeneron.
Casirivimab and Imdevimab is approved at a combined dose of 1200 mg (600 mg of each drug) administered by intravenous infusion or subcutaneous route.
It has to be stored at 2°C to 8°C. Casirivimab and Imdevimab are human immunoglobulin G-1 (IgG1) monoclonal antibodies produced by recombinant DNA technology.
How does it work?
The antibodies are specifically directed against spike protein of SARS-CoV-2 and are designed to block virus’ attachment and entry into human cells. “The cocktail remains efficacious against widest spread variants,” Roche said.
The antibody treatment was administered to former US President Donald Trump after he was diagnosed with COVID-19.
Roche will import the antibody cocktail, which will be marketed and distributed in India via a strategic partnership with Cipla Ltd.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Scientists find potential new drug target to prevent Ebola
Online wellness content: 3 ways to tell evidence-based health information from pseudoscience
Beyond Blood types – ABO Incompatible Kidney Transplant in a patient suffering from Hepatitis infections
What washing machine settings can I use to make my clothes last longer?
Dual kidney transplant on patient under dialysis performed at AIIMS-Delhi
MUST WATCH
Latest Additions
UP: Head constable held for killing government teacher, govt announces Rs 25 lakh ex gratia to kin
Gelatin sticks with detonators & other explosives recovered in Bengaluru, case filed
KPCC urges poll panel to reschedule election date in Kerala
BJP holds protest against assault on trader for playing ”Hanuman Chalisa” in Bengaluru
ED a political weapon, SC dismissed its claim that AAP got Rs 100-cr in kickbacks: Atishi